A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Calusterone
Perazine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Perazine.
Calusterone
Ritanserin
The risk or severity of adverse effects can be increased when Nabiximols is combined with Ritanserin.
Calusterone
Urapidil
The risk or severity of adverse effects can be increased when Nabiximols is combined with Urapidil.
Calusterone
Indiplon
The risk or severity of adverse effects can be increased when Nabiximols is combined with Indiplon.
Calusterone
AZD-3043
The risk or severity of adverse effects can be increased when Nabiximols is combined with AZD-3043.
Calusterone
Benzodiazepine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Benzodiazepine.
Calusterone
Raclopride
The risk or severity of adverse effects can be increased when Nabiximols is combined with Raclopride.
Calusterone
Piritramide
The risk or severity of adverse effects can be increased when Nabiximols is combined with Piritramide.
Calusterone
Ketanserin
The risk or severity of adverse effects can be increased when Nabiximols is combined with Ketanserin.
Calusterone
Orvepitant
The risk or severity of adverse effects can be increased when Nabiximols is combined with Orvepitant.
Calusterone
Bromperidol
The risk or severity of adverse effects can be increased when Nabiximols is combined with Bromperidol.
Calusterone
Esreboxetine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Esreboxetine.
Calusterone
Piclozotan
The risk or severity of adverse effects can be increased when Nabiximols is combined with Piclozotan.
Calusterone
Carisbamate
The risk or severity of adverse effects can be increased when Nabiximols is combined with Carisbamate.
Calusterone
Salvinorin A
The risk or severity of adverse effects can be increased when Nabiximols is combined with Salvinorin A.
Calusterone
Eltanolone
The risk or severity of adverse effects can be increased when Nabiximols is combined with Eltanolone.
Calusterone
Ecopipam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Ecopipam.
Calusterone
Cerlapirdine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Cerlapirdine.
Calusterone
Gepirone
The risk or severity of adverse effects can be increased when Nabiximols is combined with Gepirone.
Calusterone
Eplivanserin
The risk or severity of adverse effects can be increased when Nabiximols is combined with Eplivanserin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3